世界のウイルスベクター＆非ウイルスベクター製造＆遺伝子治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5027
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、127ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AAV、アデノウイルス、レンチウイルス、レトロウイルス、プラスミドDNA、その他ベクター）、用途別市場規模（がん、遺伝性疾患、ウイルス感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の市場動向
・企業の競争状況、市場シェア
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の種類別市場規模と予測2016-2027（AAV、アデノウイルス、レンチウイルス、レトロウイルス、プラスミドDNA、その他ベクター）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の用途別市場規模と予測2016-2027（がん、遺伝性疾患、ウイルス感染症、その他）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ウイルスベクター＆非ウイルスベクター製造＆遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BioReliance、Cobra Biologics、Oxford BioMedica、UniQure、FinVector、MolMed、MassBiologics、Richter-Helm、FUJIFILM Diosynth Biotechnologies、Lonza、Aldevron、Eurogentec、Cell and Gene Therapy Catapult、Biovian、Thermo Fisher Scientific (Brammer Bio)、VGXI、PlasmidFactory、bluebird bio、Novasep、Spark Therapeutics、Vigene Biosciences）
・結論

Market Analysis and Insights: Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
The global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market.

Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Scope and Market Size
Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AAV
Adenoviral
Lentiviral
Retroviral
Plasmid DNA
Other Vectors

Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
bluebird bio
Novasep
Spark Therapeutics
Vigene Biosciences

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AAV
1.2.3 Adenoviral
1.2.4 Lentiviral
1.2.5 Retroviral
1.2.6 Plasmid DNA
1.2.7 Other Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Perspective (2016-2027)
2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Growth Trends by Regions
2.2.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industry Dynamic
2.3.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends
2.3.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers
2.3.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges
2.3.4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue
3.4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2020
3.5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2022-2027)

5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027)
6.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type
6.2.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2027)
6.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application
6.3.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2027)
6.4 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country
6.4.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027)
7.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type
7.2.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2027)
7.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application
7.3.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2027)
7.4 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country
7.4.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type
8.2.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application
8.3.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region
8.4.1 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027)
9.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type
9.2.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application
9.3.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country
9.4.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type
10.2.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application
10.3.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country
10.4.1 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Details
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Details
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Details
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Details
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Details
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Details
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Details
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.17.5 PlasmidFactory Recent Development
11.18 bluebird bio
11.18.1 bluebird bio Company Details
11.18.2 bluebird bio Business Overview
11.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.18.4 bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.18.5 bluebird bio Recent Development
11.18 Novasep
.1 Novasep Company Details
.2 Novasep Business Overview
.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
.4 Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
.5 Novasep Recent Development
11.20 Spark Therapeutics
11.20.1 Spark Therapeutics Company Details
11.20.2 Spark Therapeutics Business Overview
11.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.20.4 Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.20.5 Spark Therapeutics Recent Development
11.21 Vigene Biosciences
11.21.1 Vigene Biosciences Company Details
11.21.2 Vigene Biosciences Business Overview
11.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
11.21.4 Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
11.21.5 Vigene Biosciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AAV
Table 3. Key Players of Adenoviral
Table 4. Key Players of Lentiviral
Table 5. Key Players of Retroviral
Table 6. Key Players of Plasmid DNA
Table 7. Key Players of Other Vectors
Table 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2016-2021)
Table 12. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2022-2027)
Table 14. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends
Table 15. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers
Table 16. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges
Table 17. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints
Table 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players (2016-2021)
Table 20. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2020)
Table 21. Ranking of Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
Table 25. Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2016-2021)
Table 29. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2016-2021)
Table 33. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 65. BioReliance Company Details
Table 66. BioReliance Business Overview
Table 67. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 68. BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 69. BioReliance Recent Development
Table 70. Cobra Biologics Company Details
Table 71. Cobra Biologics Business Overview
Table 72. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 73. Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 74. Cobra Biologics Recent Development
Table 75. Oxford BioMedica Company Details
Table 76. Oxford BioMedica Business Overview
Table 77. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 78. Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 79. Oxford BioMedica Recent Development
Table 80. UniQure Company Details
Table 81. UniQure Business Overview
Table 82. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 83. UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 84. UniQure Recent Development
Table 85. FinVector Company Details
Table 86. FinVector Business Overview
Table 87. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 88. FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 89. FinVector Recent Development
Table 90. MolMed Company Details
Table 91. MolMed Business Overview
Table 92. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 93. MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 94. MolMed Recent Development
Table 95. MassBiologics Company Details
Table 96. MassBiologics Business Overview
Table 97. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 98. MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 99. MassBiologics Recent Development
Table 100. Richter-Helm Company Details
Table 101. Richter-Helm Business Overview
Table 102. Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 103. Richter-Helm Recent Development
Table 104. FUJIFILM Diosynth Biotechnologies Company Details
Table 105. FUJIFILM Diosynth Biotechnologies Business Overview
Table 106. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 108. FUJIFILM Diosynth Biotechnologies Recent Development
Table 109. Lonza Company Details
Table 110. Lonza Business Overview
Table 111. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 112. Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 113. Lonza Recent Development
Table 114. Aldevron Company Details
Table 115. Aldevron Business Overview
Table 116. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 117. Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 118. Aldevron Recent Development
Table 119. Eurogentec Company Details
Table 120. Eurogentec Business Overview
Table 121. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 122. Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 123. Eurogentec Recent Development
Table 124. Cell and Gene Therapy Catapult Company Details
Table 125. Cell and Gene Therapy Catapult Business Overview
Table 126. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 127. Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 128. Cell and Gene Therapy Catapult Recent Development
Table 129. Biovian Company Details
Table 130. Biovian Business Overview
Table 131. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 132. Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 133. Biovian Recent Development
Table 134. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 135. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 136. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 137. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 138. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 139. VGXI Company Details
Table 140. VGXI Business Overview
Table 141. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 142. VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 143. VGXI Recent Development
Table 144. PlasmidFactory Company Details
Table 145. PlasmidFactory Business Overview
Table 146. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 147. PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 148. PlasmidFactory Recent Development
Table 149. bluebird bio Company Details
Table 150. bluebird bio Business Overview
Table 151. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 152. bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 153. bluebird bio Recent Development
Table 154. Novasep Company Details
Table 155. Novasep Business Overview
Table 156. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 157. Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 158. Novasep Recent Development
Table 159. Spark Therapeutics Company Details
Table 160. Spark Therapeutics Business Overview
Table 161. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 162. Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 163. Spark Therapeutics Recent Development
Table 164. Vigene Biosciences Company Details
Table 165. Vigene Biosciences Business Overview
Table 166. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product
Table 167. Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021) & (US$ Million)
Table 168. Vigene Biosciences Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. AAV Features
Figure 3. Adenoviral Features
Figure 4. Lentiviral Features
Figure 5. Retroviral Features
Figure 6. Plasmid DNA Features
Figure 7. Other Vectors Features
Figure 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2020 VS 2027
Figure 9. Cancers Case Studies
Figure 10. Inherited Disorders Case Studies
Figure 11. Viral Infections Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Report Years Considered
Figure 14. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions: 2020 VS 2027
Figure 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2022-2027)
Figure 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players in 2020
Figure 19. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2020
Figure 21. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2016-2021)
Figure 22. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2022-2027)
Figure 23. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2016-2027)
Figure 25. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2016-2027)
Figure 26. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027)
Figure 27. United States Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2016-2027)
Figure 31. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2016-2027)
Figure 32. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027)
Figure 33. Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Region (2016-2027)
Figure 43. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2016-2027)
Figure 51. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2016-2027)
Figure 52. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027)
Figure 53. Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Country (2016-2027)
Figure 59. Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. BioReliance Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 63. Cobra Biologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 64. Oxford BioMedica Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 65. UniQure Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 66. FinVector Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 67. MolMed Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 68. MassBiologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 69. Richter-Helm Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 70. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 71. Lonza Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 72. Aldevron Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 73. Eurogentec Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 74. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 75. Biovian Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 76. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 77. VGXI Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 78. PlasmidFactory Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 79. bluebird bio Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 80. Novasep Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 81. Spark Therapeutics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 82. Vigene Biosciences Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2016-2021)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

以下、関連資料のご紹介

世界のウイルスベクター市場規模・現状・予測（2021年-2027年）

Global Viral Vectors Market Size, Status and Forecast 2021-2027
QFJ1-5026 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、ウイルスベクターの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レトロウイルスベクター、レンチウイルスベクター、アデノウイルスベクター、単純ヘルペスウイルスベクター、キメラウイルスベクター、その他）、...

世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3985 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO...

世界の遺伝子治療医学市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicine Market Size, Status and Forecast 2021-2027
QFJ1-5751 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医学の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年）

Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4246 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遺伝子検出用個別化癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査）、用途別市場規模（病院、クリニック、診断センタ...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Tools and Reagents Market Size, Status and Forecast 2021-2027
QFJ1-5121 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、細胞・遺伝子治療用ツール＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学発光免疫測定法（CLIA）、フルオロイムノアッセイ、マルチプレックスアッセイ、迅速診断技術）、用途別市場規模（病院、研...

世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5749 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、遺伝子治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経筋疾患、遺伝病、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の細胞＆遺伝子治療製造QC市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Manufacturing QC Market Size, Status and Forecast 2021-2027
QFJ1-3986 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療製造QCの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性試験、純度試験、効力試験、同一性試験、安定性試験）、用途別市場規模（精密治療、生物研究所）、主要地域別市場規模（北米、アメ...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界のウイルスベクター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Vectors Market The global Viral Vectors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brillia…
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界のウイルス性疾患診断市場規模・現状・予測（2021年-2027年） Viral Disease Diagnosis is based on clinical features and pathological data to determine the possible infection of viruses. Then according to the biological characteristics of suspicious viruses, immune response and clinical process, combined with the patient's current time. Market Analysis and Insi…
世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年） In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome. Gene therapy has the potential to cure …
世界の節足動物媒介性ウイルス感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Arthropod-borne Viral Infections Testing Market The global Arthropod-borne Viral Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…